Vericel (VCEL) Shares Outstanding (Diluted Average) (2010 - 2026)

Vericel's (VCEL) quarterly Shares Outstanding (Diluted Average) came in at $50.8 million in Q1 2026, up 1.74% year-on-year from $49.9 million in Q1 2025, and down 2.64% quarter-over-quarter from $52.2 million in Q4 2025.

Vericel (VCEL) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends

Vericel has disclosed Shares Outstanding (Diluted Average) across 12 years of filings, most recently posting $50.8 million for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $50.8 million, up 1.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $50.8 million (up 1.74% YoY), and the FY2025 annual result was $52.2 million, up 0.91% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $50.8 million for Q1 2026 at Vericel, down from $52.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $52.2 million in Q4 2025 to a low of $47.0 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $48.1 million (2024), against an average of $48.8 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) advanced 0.86% in 2023 and climbed 8.59% in 2024, its largest moves.
  • Vericel's Shares Outstanding (Diluted Average) stood at $47.1 million in 2022, then increased by 0.98% to $47.6 million in 2023, then increased by 8.59% to $51.7 million in 2024, then gained by 0.91% to $52.2 million in 2025, then fell by 2.64% to $50.8 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $50.8 million (Q1 2026), $52.2 million (Q4 2025), and $50.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn 50.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.77 Mn
Dec 31, 2025 52.15 Mn
Sep 30, 2025 50.26 Mn
Jun 30, 2025 50.37 Mn
Mar 31, 2025 49.91 Mn
Dec 31, 2024 51.68 Mn
Sep 30, 2024 49.09 Mn
Jun 30, 2024 48.69 Mn
Mar 31, 2024 48.14 Mn
Dec 31, 2023 47.59 Mn
Sep 30, 2023 47.65 Mn
Jun 30, 2023 47.48 Mn
Mar 31, 2023 47.39 Mn
Dec 31, 2022 47.13 Mn
Sep 30, 2022 47.18 Mn
Jun 30, 2022 47.05 Mn
Mar 31, 2022 46.99 Mn
Dec 31, 2021 46.47 Mn
Sep 30, 2021 46.67 Mn
Jun 30, 2021 46.40 Mn